Wikidata

(Q113888323)

English

Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

country
Taiwan
0 references
start time
February 2015
0 references
end time
July 2021
0 references
number of participants
200
0 references
research intervention
valproic acid
0 references
enzyme inhibitor
0 references
mechanism of action
0 references
GABA agents
0 references
neurotransmitter agent
0 references
antimanic agents
0 references
neuroleptic
0 references
depressant
0 references
psychotropic drug
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q113888323&oldid=2149426368"